1 | Epoprostenol (D00106) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
(D00106),
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
2 | Epoprostenol FOR injection (D00106) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
(D00106),
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
3 | Epoprostenol sodico (D00106) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
(D00106),
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
4 | Epoprostenol sodium (D00106) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
(D00106),
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
5 | Epoprostenol-actelion (D00106) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
(D00106),
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
6 | NEW thermo stable formulation OF epoprostenol sodium (D00106) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
(D00106),
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|